Business Briefing: Gilead Ordered to Pay Merck $200 Million in Patent Dispute
Friday, March 25, 2016 - 00:51
in Mathematics & Economics
A federal jury on Thursday ordered Gilead Sciences to pay for infringing two Merck patents related to a lucrative cure for hepatitis C.